quinazolines has been researched along with Cardiac Output, Low in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Janssen, PA; Reneman, RS; Van de Water, A; Xhonneux, R | 1 |
| Beck, E; Conrad, C; de Chaffoy de Courcelles, D; Heers, C; Peters, T; Schneider, J; Wilffert, B | 1 |
| Esato, K; Katoh, T; Miyamoto, M; Mori, F | 1 |
| Fukuta, S; Itagaki, T; Kusukawa, R; Toma, Y; Umemoto, S; Yamakawa, K; Yoshinaga, T | 1 |
4 other study(ies) available for quinazolines and Cardiac Output, Low
| Article | Year |
|---|---|
Cardiac and hemodynamic effects of intravenous R80122, a new phosphodiesterase III inhibitor, in a canine model of myocardial ischemia and heart failure.
Topics: Animals; Blood Pressure; Cardiac Output, Low; Dogs; Female; Heart Rate; Hemodynamics; Imidazoles; Infusions, Intravenous; Male; Milrinone; Myocardial Ischemia; Phosphodiesterase Inhibitors; Pyridones; Quinazolines; Vascular Resistance; Ventricular Function, Left | 1992 |
Cardiac effects of R 79595 and its isomers (R 80122 and R 80123) in an acute heart failure model. A new class of cardiotonic agents with highly selective phosphodiesterase III inhibitory properties.
Topics: Animals; Cardiac Output; Cardiac Output, Low; Cardiotonic Agents; Female; Guinea Pigs; Heart; Heart Rate; Heart Ventricles; Hexobarbital; Imidazoles; In Vitro Techniques; Isoenzymes; Isoproterenol; Male; Phosphodiesterase Inhibitors; Quinazolines | 1992 |
Effect of combined dopamine and bunazosin on the ischemic heart after occlusion of the coronary artery.
Topics: Adrenergic alpha-Antagonists; Animals; Arterial Occlusive Diseases; Cardiac Output, Low; Coronary Circulation; Coronary Disease; Dogs; Dopamine; Drug Evaluation, Preclinical; Drug Therapy, Combination; Hemodynamics; Infusions, Intravenous; Myocardium; Oxygen Consumption; Quinazolines | 1990 |
Hemodynamic benefits of long-term bunazosin (alpha-1 blocker) therapy in rats with myocardial infarction and heart failure.
Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Cardiac Output, Low; Chronic Disease; Female; Heart Ventricles; Hemodynamics; Myocardial Infarction; Quinazolines; Rats; Rats, Inbred Strains; Vascular Resistance; Weight Gain | 1989 |